These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18022387)

  • 1. Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway.
    Russo I; Del Mese P; Viretto M; Doronzo G; Mattiello L; Trovati M; Anfossi G
    Clin Biochem; 2008 Mar; 41(4-5):343-9. PubMed ID: 18022387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.
    Russo I; Doronzo G; Mattiello L; De Salve A; Trovati M; Anfossi G
    Thromb Res; 2004; 114(4):265-73. PubMed ID: 15381390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen ameliorates trauma-hemorrhage-induced lung injury via endothelial nitric oxide synthase-dependent activation of protein kinase G.
    Kan WH; Hsu JT; Schwacha MG; Choudhry MA; Bland KI; Chaudry IH
    Ann Surg; 2008 Aug; 248(2):294-302. PubMed ID: 18650641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
    Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of lamellipodial structure and dynamics by NO-dependent phosphorylation of VASP Ser239.
    Lindsay SL; Ramsey S; Aitchison M; Renné T; Evans TJ
    J Cell Sci; 2007 Sep; 120(Pt 17):3011-21. PubMed ID: 17684063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
    Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
    Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxynitrite causes phosphorylation of vasodilator-stimulated phosphoprotein through a PKC dependent mechanism.
    Aburima A; Riba R; Naseem KM
    Platelets; 2010; 21(6):421-8. PubMed ID: 20624010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant.
    Eckert RE; Jones SL
    J Leukoc Biol; 2007 Nov; 82(5):1311-21. PubMed ID: 17684042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of VASP with TRPC4 in PKG-mediated inhibition of the store-operated calcium response in mesangial cells.
    Wang X; Pluznick JL; Settles DC; Sansom SC
    Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1768-76. PubMed ID: 17913834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein.
    Russo I; Del Mese P; Doronzo G; De Salve A; Secchi M; Trovati M; Anfossi G
    Clin Chem; 2007 Jun; 53(6):1053-60. PubMed ID: 17463178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
    Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R
    EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling.
    Ibarra-Alvarado C; Galle J; Melichar VO; Mameghani A; Schmidt HH
    Mol Pharmacol; 2002 Feb; 61(2):312-9. PubMed ID: 11809855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
    Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J
    Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
    Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR
    J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of vasodilator-stimulated phosphoprotein: a consequence of nitric oxide- and cGMP-mediated signal transduction in brain capillary endothelial cells and astrocytes.
    Sporbert A; Mertsch K; Smolenski A; Haseloff RF; Schönfelder G; Paul M; Ruth P; Walter U; Blasig IE
    Brain Res Mol Brain Res; 1999 Apr; 67(2):258-66. PubMed ID: 10216224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
    Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J
    Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response.
    Meinecke M; Geiger J; Butt E; Sandberg M; Jahnsen T; Chakraborty T; Walter U; Jarchau T; Lohmann SM
    Mol Pharmacol; 1994 Aug; 46(2):283-90. PubMed ID: 8078490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible nitric oxide synthase-dependent stimulation of PKGI and phosphorylation of VASP in human embryonic kidney cells.
    André M; Latado H; Felley-Bosco E
    Biochem Pharmacol; 2005 Feb; 69(4):595-602. PubMed ID: 15670578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.